USPTO serial 79301986
Reviewed by CopyMark Law Group
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
| Class | Description | Status | First use |
|---|---|---|---|
| 010 | Flasks for parenteral nutrition, namely, container and drug reconstitution system for injections and infusions, all being medical apparatus in the nature of infusion and injection devices for administering drugs; drug delivery devices sold empty, namely, flasks for medical use; dropper bottles for administering medication, sold empty, for medical purposes; vaporizers for medical purposes; suction bottles for medical use, namely, feeding bottles, nursing bottles, and dropper bottles for administering medication, sold empty; dropper bottles for administering medication, sold empty; syringes for medical purposes; syringes for injections; haemoperfusion cartridges being structural part of dialysis machines and blood containers for medical purposes; feeding bottles; droppers for administering medication, sold empty, for medical purposes; droppers for administering medication, sold empty; medical trays for holding surgical instruments; measuring spoons for administering medicine; spoons for administering medicine; non-spill medicine spoons for infants; intravenous feeding bottles; medicinal bottle stoppers, namely, bottle stoppers specifically adapted for feeding bottles and baby bottles; breast milk storage bottles; medical tubing for administering drugs; injection device for pharmaceuticals; dropping pipettes for medical purposes; containers made of glass or plastic for pharmaceutical or parapharmaceutical or medical use, namely, bottles for injectable substances, bottles for medicines, bottles for reagents, bottles for infusions, bottles for aerosols, vials, ampoules, cartridges, syringes, and pill bottles; diagnostic devices, namely, sample preparation device for medical diagnostic use, blood pressure and diabetic diagnostic medical devices, and diagnostic kit consisting primarily of probes, buffers and reagents for use in microbial testing used in laboratories for Point of Care Testing (POCT) for integrated electronic systems for the administration of medical substances; cartridges of plastic for diagnostic purposes, namely, replacement and structural components of medical diagnostic apparatus for detecting diseases, integrated electronic system for the administration of medical substances being delivery systems and medical instruments for measuring and displaying blood pressure and lung capacity; consumable laboratory cartridges for diagnostic use in laboratories, namely, replacement and structural components of medical diagnostic apparatus for detecting diseases, integrated electronic system for the administration of medical substances being drug delivery systems and medical instruments for measuring and displaying blood pressure and lung capacity; valves and accessories for intravenous drug administration of medicinal products, namely, subcutaneous valves comprised of artificial material for implantation, feeding bottle valves, intravenous bags sold empty for intravenous therapy, intravenous feeding tubes, replacement and structural parts of injection devices for administering drugs in the nature of stoppers, connectors and IV extensions and IV cannulas, and stopcocks; medical diagnostic apparatus for sale in kit form for medical diagnostic purposes, namely, diagnostic kits consisting primarily of probes, buffers, and reagents for use in microbial testing; clinical-medical test kits for clinical medical use containing test tubes, test plates and indicator charts for evaluating test results; containers for medical reagents, namely, containers specially designed for transporting and holding radiopharmaceuticals; integrated electronic systems for administering medical substances comprised primarily of medical apparatus for intravenous administration of fluids in the nature of fluid warmers, spoons for administering medicine, intravenous feeding tubes and also containing computer hardware and software for administering medical substances; integrated electronic systems for the registration of medical data comprised primarily of medical devices used for the acquisition of physiological data for polysomnography, medical instruments for measuring and displaying medical data in the nature of blood pressures and lung capacity and also containing computer hardware and software for registering medical data; integrated electronic systems for the registration of pharmaceutical data comprised primarily of medical apparatus for introduction pharmaceutical preparations into the human body, medical instruments for measuring and displaying medical data in the nature of blood pressures and lung capacity, injection devices for pharmaceuticals and also containing computer hardware and software for registering pharmaceutical data; medical prostheses for breast, hand and implants consisting of artificial materials for surgical purposes; sterile containers to be filled with medical products, namely, containers for medical waste, blood containers for medical purposes sold empty; sterile containers for surgical purposes, namely, containers for medical waste, blood containers for medical purposes sold empty; cartridges of plastic for containing and administering medical products for diagnostic use in laboratories for Point of Care Testing (POCT), namely, medical apparatus in the nature of infusion and injection devices for administering drugs; cartridges of glass for containing and administering medical products for diagnostic use in laboratories for Point of Care Testing (POCT), namely, medical apparatus in the nature of infusion and injection devices for administering drugs; cartridges of plastic for containing and administering reagents as parts of ultrasonic medical diagnostic apparatus; cartridges of glass for containing and administering reagents as parts of ultrasonic medical diagnostic apparatus; needles of metal for parenteral administration; drug recovery accessories, namely, drug delivery systems | ACTIVE | — |
| 020 | Container closures of plastic; plastic medication containers for commercial use; containers, not of metal, for commercial use; bottle closures, not of metal; closures for containers, non-metallic; corks for bottles; plastic stoppers for bottles; screwcaps and caps of plastic for the closure of containers; sealing caps, not of metal; closures of plastics for containers for detecting tampering, namely, locking plastic cap that covers bung openings in plastic and metal containers for tamper evidence | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 20, 2022 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Aug 26, 2022 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Aug 25, 2022 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jul 12, 2022 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Apr 12, 2022 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jan 25, 2022 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 25, 2022 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 22, 2022 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jan 5, 2022 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jan 5, 2022 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jan 5, 2022 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Dec 20, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 20, 2021 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Dec 20, 2021 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Dec 20, 2021 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Dec 20, 2021 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Nov 16, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 16, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 16, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 16, 2021 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Nov 16, 2021 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Nov 16, 2021 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Nov 16, 2021 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 16, 2021 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Nov 16, 2021 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Jun 7, 2021 | RFNT | REFUSAL PROCESSED BY IB | — |
| May 19, 2021 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| May 19, 2021 | RFRR | REFUSAL PROCESSED BY MPU | — |
| May 19, 2021 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| May 18, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 12, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 15, 2021 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jan 11, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 7, 2021 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |